Vanda Pharmaceuticals
VNDA
$4.62
Share price
3.12%
Change (1 day)
-24.76%
Change (1 year)
Categories
Operating Margin for Vanda Pharmaceuticals (VNDA)
Operating Margin as of April 2024 (TTM): 6.23%
According to Vanda Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 6.23%. At the end of 2021 the company had an Operating Margin of 15.77%.
Operating Margin history for Vanda Pharmaceuticals from 2010 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 15.77% | 23.61% |
| 2020 | 12.76% | -0.17% |
| 2019 | 12.78% | -2.65% |
| 2018 | 13.12% | -240.41% |
| 2017 | -9.35% | -23.78% |
| 2016 | -12.26% | -66.19% |
| 2015 | -36.27% | -190.11% |
| 2014 | 40.25% | -167.32% |
| 2013 | -59.79% | -29.27% |
| 2012 | -84.53% | 157.98% |
| 2011 | -32.77% | -226.23% |
| 2010 | 25.96% | -103.29% |
| 2009 | -788.50% | |
| 2004 | -27,867.38% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | 267.26% | 🇺🇸 USA |
 Novartis NVS | 17.27% | 177.21% | 🇨🇭 Switzerland |
 Pfizer PFE | 34.61% | 455.54% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | 295.83% | 🇺🇸 USA |
 Merck MRK | 27.73% | 345.10% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | 208.83% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | -2,570.78% | -41,364.53% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.